BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 29164766)

  • 1. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition.
    Zhang W; Zhou P; Meng A; Zhang R; Zhou Y
    J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
    Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
    J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual effects of collagenase-3 on melanoma: metastasis promotion and disruption of vasculogenic mimicry.
    Zhao X; Sun B; Li Y; Liu Y; Zhang D; Wang X; Gu Q; Zhao J; Dong X; Liu Z; Che N
    Oncotarget; 2015 Apr; 6(11):8890-9. PubMed ID: 25749207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myoferlin depletion in breast cancer cells promotes mesenchymal to epithelial shape change and stalls invasion.
    Li R; Ackerman WE; Mihai C; Volakis LI; Ghadiali S; Kniss DA
    PLoS One; 2012; 7(6):e39766. PubMed ID: 22761893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoferlin silencing inhibits VEGFR2-mediated proliferation of metastatic clear cell renal cell carcinoma.
    An HJ; Song DH; Koh HM; Kim YM; Ko GH; Lee JH; Lee JS; Yang JW; Kim MH; Seo DH; Jang SM; Kim DC
    Sci Rep; 2019 Sep; 9(1):12656. PubMed ID: 31477752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Delta-like 3 restricts lipopolysaccharide-induced inflammation, migration and invasion of A2058 melanoma cells via blocking Twist1-mediated epithelial-mesenchymal transition.
    Ding X; Li F; Zhang L
    Life Sci; 2019 Jun; 226():149-155. PubMed ID: 30981764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.
    Cao Z; Sun B; Zhao X; Zhang Y; Gu Q; Liang X; Dong X; Zhao N
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of myoferlin redirects breast cancer cell motility towards collective migration.
    Volakis LI; Li R; Ackerman WE; Mihai C; Bechel M; Summerfield TL; Ahn CS; Powell HM; Zielinski R; Rosol TJ; Ghadiali SN; Kniss DA
    PLoS One; 2014; 9(2):e86110. PubMed ID: 24586247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of STAT3 Promotes Vasculogenic Mimicry by Inducing Epithelial-to-Mesenchymal Transition in Colorectal Cancer.
    Han C; Sun B; Zhao X; Zhang Y; Gu Q; Liu F; Zhao N; Wu L
    Technol Cancer Res Treat; 2017 Dec; 16(6):1209-1219. PubMed ID: 29333928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myoferlin depletion elevates focal adhesion kinase and paxillin phosphorylation and enhances cell-matrix adhesion in breast cancer cells.
    Blackstone BN; Li R; Ackerman WE; Ghadiali SN; Powell HM; Kniss DA
    Am J Physiol Cell Physiol; 2015 Apr; 308(8):C642-9. PubMed ID: 25631868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TAZ promotes vasculogenic mimicry in gastric cancer through the upregulation of TEAD4.
    Zhang Y; Bai J; Cheng R; Zhang D; Qiu Z; Liu T; Che N; Dong X; Zhao N; Lin X; Liang X; Li F; Li Y; Sun B; Zhao X
    J Gastroenterol Hepatol; 2022 Apr; 37(4):714-726. PubMed ID: 35062042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PD-L1 knockdown suppresses vasculogenic mimicry of non-small cell lung cancer by modulating ZEB1-triggered EMT.
    Li W; Wu J; Jia Q; Shi Y; Li F; Zhang L; Shi F; Wang X; Wu S
    BMC Cancer; 2024 May; 24(1):633. PubMed ID: 38783271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
    Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
    J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma.
    Meng J; Sun B; Zhao X; Zhang D; Zhao X; Gu Q; Dong X; Zhao N; Liu P; Liu Y
    Mol Cancer Ther; 2014 Dec; 13(12):3107-22. PubMed ID: 25277383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MMP-2 and MMP-13 affect vasculogenic mimicry formation in large cell lung cancer.
    Li Y; Sun B; Zhao X; Wang X; Zhang D; Gu Q; Liu T
    J Cell Mol Med; 2017 Dec; 21(12):3741-3751. PubMed ID: 28766880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch4 inhibition suppresses invasion and vasculogenic mimicry formation of hepatocellular carcinoma cells.
    Cheng R; Cai XR; Ke K; Chen YL
    J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):719-725. PubMed ID: 29058285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-2α promotes the formation of vasculogenic mimicry in pancreatic cancer by regulating the binding of Twist1 to the VE-cadherin promoter.
    Yang J; Zhu DM; Zhou XG; Yin N; Zhang Y; Zhang ZX; Li DC; Zhou J
    Oncotarget; 2017 Jul; 8(29):47801-47815. PubMed ID: 28599281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.